CURIA GLOBAL INC - EXPLORATORY CHEMISTRY AND HIT-TO-LEAD CHEMISTRY OPTION. MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP). POP: SEPTEMBER 21, 2026 TO MARCH 20, 2029. DAP-NCAP-00000137

PIID: 75N98026F00001Solicitation ID: NINDS-26-01
Signed Date: Sep 18, 2026Effective Date: Sep 21, 2026End Date: Closes in 878 days
Award $
$2.1M
Vendor
CURIA GLOBAL INC
NAICS
541715
Signed Date
Sep 18, 2026

Key Details

Dollars Obligated
$2.1M
Base & All Options
$3.8M
Awarding Sub-Agency
National Institutes of Health
Parent IDIQ (PIID)
HHSN271201800001I
Product Service Code
AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
ALBANY, NY

Description

EXPLORATORY CHEMISTRY AND HIT-TO-LEAD CHEMISTRY OPTION. MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP). POP: SEPTEMBER 21, 2026 TO MARCH 20, 2029. DAP-NCAP-00000137

Context & Analysis

On Sep 18, 2026, Department of Health and Human Services obligated $2,138,209.31 to CURIA GLOBAL INC for exploratory chemistry and hit-to-lead chemistry option. medicinal chemistry support program for therapeutic development (mcsp). pop: september 21, 2026 to march 20, 2029. dap-ncap-00000137. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). Competition extent: full and open competition. Performance is located in ALBANY, NY. The contract is scheduled through Mar 20, 2029. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.

Contractor Information

Contractor: CURIA GLOBAL INC
UEI: ELCNZCS8GEA3
Location: ALBANY, NY

Stay Updated

Get notified about new opportunities matching your interests.

Related